158 related articles for article (PubMed ID: 17391059)
21. SUMO modification regulates the transcriptional activity of FLASH.
Alm-Kristiansen AH; Norman IL; Matre V; Gabrielsen OS
Biochem Biophys Res Commun; 2009 Sep; 387(3):494-9. PubMed ID: 19615980
[TBL] [Abstract][Full Text] [Related]
22. FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.
Kobayashi S; Shibata H; Yokota K; Suda N; Murai A; Kurihara I; Saito I; Saruta T
Endocr Res; 2004 Nov; 30(4):617-21. PubMed ID: 15666801
[TBL] [Abstract][Full Text] [Related]
23. Ubc9 sumoylation regulates SUMO target discrimination.
Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
[TBL] [Abstract][Full Text] [Related]
24. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
25. Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the Co-repressor of the KRAB Multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain.
Mascle XH; Germain-Desprez D; Huynh P; Estephan P; Aubry M
J Biol Chem; 2007 Apr; 282(14):10190-202. PubMed ID: 17298944
[TBL] [Abstract][Full Text] [Related]
26. The SUMOylation of zinc-fingers and homeoboxes 1 (ZHX1) by Ubc9 regulates its stability and transcriptional repression activity.
Chen S; Yu X; Lei Q; Ma L; Guo D
J Cell Biochem; 2013 Oct; 114(10):2323-33. PubMed ID: 23686912
[TBL] [Abstract][Full Text] [Related]
27. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.
Ivanov AV; Peng H; Yurchenko V; Yap KL; Negorev DG; Schultz DC; Psulkowski E; Fredericks WJ; White DE; Maul GG; Sadofsky MJ; Zhou MM; Rauscher FJ
Mol Cell; 2007 Dec; 28(5):823-37. PubMed ID: 18082607
[TBL] [Abstract][Full Text] [Related]
28. Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function.
Priyanka ; Kotiya D; Rana M; Subbarao N; Puri N; Tyagi RK
Mol Cell Endocrinol; 2016 Jan; 420():194-207. PubMed ID: 26549688
[TBL] [Abstract][Full Text] [Related]
29. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
30. Deletion of the GATA domain of TRPS1 causes an absence of facial hair and provides new insights into the bone disorder in inherited tricho-rhino-phalangeal syndromes.
Malik TH; Von Stechow D; Bronson RT; Shivdasani RA
Mol Cell Biol; 2002 Dec; 22(24):8592-600. PubMed ID: 12446778
[TBL] [Abstract][Full Text] [Related]
31. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.
Piscopo DM; Johansen EB; Derynck R
J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Nakagawa K; Kuzumaki N
Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
[TBL] [Abstract][Full Text] [Related]
33. Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene.
Kuo FT; Bentsi-Barnes IK; Barlow GM; Bae J; Pisarska MD
Cell Signal; 2009 Dec; 21(12):1935-44. PubMed ID: 19744555
[TBL] [Abstract][Full Text] [Related]
34. The polycomb protein Pc2 is a SUMO E3.
Kagey MH; Melhuish TA; Wotton D
Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
[TBL] [Abstract][Full Text] [Related]
35. Multiple activities contribute to Pc2 E3 function.
Kagey MH; Melhuish TA; Powers SE; Wotton D
EMBO J; 2005 Jan; 24(1):108-19. PubMed ID: 15592428
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
[TBL] [Abstract][Full Text] [Related]
37. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
38. Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression.
Rohira AD; Chen CY; Allen JR; Johnson DL
J Biol Chem; 2013 Jun; 288(26):19288-95. PubMed ID: 23673667
[TBL] [Abstract][Full Text] [Related]
39. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
Wu YC; Roark AA; Bian XL; Wilson VG
Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
[TBL] [Abstract][Full Text] [Related]
40. SUMOylation attenuates c-Maf-dependent IL-4 expression.
Lin BS; Tsai PY; Hsieh WY; Tsao HW; Liu MW; Grenningloh R; Wang LF; Ho IC; Miaw SC
Eur J Immunol; 2010 Apr; 40(4):1174-84. PubMed ID: 20127678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
